Pär‐Ola Bendahl

9.9k citations

181 papers · 6.7k indexed · h-index 44

Oncology top 0.5%
Cancer Research top 0.5%
Molecular Biology top 2%
Pulmonary and Respiratory Medicine top 2%
Genetics top 2%

Co-authors: Mårten Fernö Lisa Rydén Åke Borg Dorthe Grabau Lao H. Saal Sofia K. Gruvberger-Saal Mef Nilbert Cecilia Hegardt
Topics: Breast Cancer Treatment Studies (61 papers)HER2/EGFR in Cancer Research (36 papers)Cancer Genomics and Diagnostics (27 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Blood
Partner nations: Sweden Denmark United States

In The Last Decade

Pär‐Ola Bendahl

175 papers receiving 6.6k citations

Peers

Countries citing papers authored by Pär‐Ola Bendahl

Since Specialization

Citations

This map shows the geographic impact of Pär‐Ola Bendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär‐Ola Bendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär‐Ola Bendahl more than expected).

Fields of papers citing papers by Pär‐Ola Bendahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär‐Ola Bendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär‐Ola Bendahl. The network helps show where Pär‐Ola Bendahl may publish in the future.

Co-authorship network of co-authors of Pär‐Ola Bendahl

This figure shows the co-authorship network connecting the top 25 collaborators of Pär‐Ola Bendahl. A scholar is included among the top collaborators of Pär‐Ola Bendahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär‐Ola Bendahl. Pär‐Ola Bendahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep learning on routine full-breast mammograms enhances lymph node metastasis prediction in early breast cancer 2025 ·npj Digital Medicine ·(unknown),(unknown),Pär‐Ola Bendahl,Ida Arvidsson,Magnus Dustler,(unknown),(unknown),(unknown),Mattias Ohlsson,(unknown),David Schmidt,Sophia Zackrisson,Patrik Edén,Lisa Rydén	0
2	Preoperative prediction of nodal status using clinical data and artificial intelligence derived mammogram features enabling abstention of sentinel lymph node biopsy in breast cancer 2024 ·Frontiers in Oncology ·(unknown),(unknown),Pär‐Ola Bendahl,Daniel Förnvik,Magnus Dustler,Lisa Rydén	2
3	Model of Health-Related Quality of Life in Breast Cancer Patients Using Cross-Sectional Data: The Role of Resilience 2024 ·Cancer Management and Research ·(unknown),Ulrika Möller,Lisa Rydén,Pär‐Ola Bendahl,Marlene Malmström	0
4	Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long‐term follow‐up of the SweBCG91RT randomized trial 2023 ·Molecular Oncology ·(unknown),Tommaso De Marchi,Gyula Pekár,Lena Tran,Pär‐Ola Bendahl,(unknown),Erik Holmberg,Per Karlsson,Marianne Farnebo,Fredrika Killander,Emma Niméus	3
5	Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin 2023 ·Cancers ·Pär‐Ola Bendahl,Mattias Belting,(unknown)	7
6	The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer 2022 ·Breast Cancer Research and Treatment ·(unknown),(unknown),(unknown),(unknown),Mattias Ohlsson,(unknown),Pär‐Ola Bendahl,Katarina Steen Carlsson,Lisa Rydén	6
7	Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer 2020 ·Scientific Reports ·Anna-Maria Larsson,Pär‐Ola Bendahl,Kristina Aaltonen,Sara Jansson,Carina Forsare,Mattias Bergqvist,(unknown),Lisa Rydén	15
8	Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence 2019 ·Acta Oncologica ·Sofi Isaksson,Anthony M. George,Mats Jönsson,Helena Cirenajwis,Per Jönsson,Pär‐Ola Bendahl,Hans Brunnström,Johan Staaf,Lao H. Saal,Maria Planck	19
9	Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort 2019 ·Clinical Cancer Research ·(unknown),Johan Vallon‐Christersson,Cecilia Hegardt,Lao H. Saal,Jari Häkkinen,Christer Larsson,Anna Ehinger,Niklas Loman,Martin Malmberg,Pär‐Ola Bendahl,Åke Borg,Johan Staaf,Lisa Rydén	37
10	Global Transcriptional Changes Following Statin Treatment in Breast Cancer 2015 ·Clinical Cancer Research ·Olöf Bjarnadottir,Siker Kimbung,Ida Johansson,Srinivas Veerla,Mats Jönsson,Pär‐Ola Bendahl,Dorthe Grabau,Ingrid Hedenfalk,Signe Borgquist	45
11	The role of histological grade in discrimination between Luminal A-like and Luminal B-like subtypes in a series of premenopausal breast cancer patients 2014 ·Lund University Publications (Lund University) ·Anna Ehinger,Pär‐Ola Bendahl,C.W. Elston,Per Malmström,Dorthe Grabau,Mårten Fernö	2
12	G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients 2013 ·Clinical Cancer Research ·Stefan Broselid,Benxu Cheng,Martin Sjöström,Kristina Lövgren,(unknown),Mattias Belting,Karin Jirström,Per Malmström,Björn Olde,Pär‐Ola Bendahl,Linda Hartman,Mårten Fernö,L.M. Fredrik Leeb-Lundberg	35
13	Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years’ follow-up 2013 ·Breast Cancer Research and Treatment ·(unknown),Pär‐Ola Bendahl,Gunilla Chebil,Hans Olsson,Mårten Fernö,Lisa Rydén	47
14	The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer 2013 ·PLoS ONE ·Marie Klintman,Carina Strand,Cecilia Ahlin,(unknown),Marie-Louise Fjällskog,Dorthe Grabau,Einar Gudlaugsson,Emiel A. M. Janssen,Kristina Lövgren,Ivar Skaland,Pär‐Ola Bendahl,Per Malmström,Jan P. A. Baak,Mårten Fernö	24
15	Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma 2012 ·Clinical Cancer Research ·Katja Harbst,Johan Staaf,Martin Lauss,Anna Karlsson,Anna Måsbäck,Iva Johansson,Pär‐Ola Bendahl,Johan Vallon‐Christersson,Therese Törngren,Henrik Ekedahl,Jürgen Geisler,Mattias Höglund,Markus Ringnér,Lotta Lundgren,Karin Jirström,Håkan Olsson,Christian Ingvar,Åke Borg,Hensin Tsao,Göran Jönsson	72
16	Prediction of outcome after diagnosis of metachronous contralateral breast cancer 2011 ·BMC Cancer ·Sara Alkner,Pär‐Ola Bendahl,Mårten Fernö,Jonas Manjer,Lisa Rydén	32
17	Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1 2010 ·Cancer Research ·Jeanette Nilsson,Khalil Helou,Anikó Kovács,Pär‐Ola Bendahl,Gunnar Bjursell,Mårten Fernö,Peter Carlsson,Marie Kannius‐Janson	58
18	Reproducibility of human epidermal growth factor receptor 2 analysis in primary breast cancer – A national survey performed at pathology departments in Sweden 2009 ·Acta Oncologica ·Lisa Rydén,(unknown),Pär‐Ola Bendahl,Thomas Hatschek,(unknown),Anikó Kovács,(unknown),Hans Olsson,Carina Strand,Mårten Fernö,(unknown)	23
19	Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma 2007 ·Clinical Cancer Research ·Sofia K. Gruvberger-Saal,Pär‐Ola Bendahl,Lao H. Saal,Mervi Laakso,Cecilia Hegardt,P. Edén,Carsten Peterson,Per Malmström,Jorma Isola,Åke Borg,Mårten Fernö	154
20	Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival 2003 ·European Journal of Cancer ·Mads Holten-Andersen,I. J. Christensen,Mef Nilbert,Pär‐Ola Bendahl,Hans Jørgen Nielsen,N. Brünner,Eva Fernebro	46

About Pär‐Ola Bendahl

Pär‐Ola Bendahl is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 181 papers that have together received 6.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (61 papers), HER2/EGFR in Cancer Research (36 papers) and Cancer Genomics and Diagnostics (27 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (3.3k citations) and Pathology and Forensic Medicine (780 citations). Pär‐Ola Bendahl has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Mårten Fernö, Lisa Rydén, Åke Borg, Dorthe Grabau, Lao H. Saal, Sofia K. Gruvberger-Saal, Mef Nilbert, Cecilia Hegardt, Kristina Lövgren and Markus Ringnér. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact